Identification of CD112R as a novel checkpoint for human T cells

Journal of Experimental Medicine

Volumn 213, Issue 2, 2016, Pages 167-176

  Zhu, Yuwen ^a   Paniccia, Alessandro ^a   Schulick, Alexander C ^a   Chen, Wei ^a,b   Koenig, Michelle R ^a   Byers, Joshua T ^a   Yao, Sheng ^c   Bevers, Shaun ^a   Edil, Barish H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c TopAlliance Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; LYMPHOCYTE ANTIGEN RECEPTOR; NECTIN 2; NECTIN 2 RECEPTOR; UNCLASSIFIED DRUG; CD112 RECEPTOR, HUMAN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; HYBRID PROTEIN; IL2RB PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR BETA; LIGAND; NECTINS; POLIOVIRUS RECEPTOR; T LYMPHOCYTE ANTIGEN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ARTICLE; CELL CYCLE CHECKPOINT; CELL DIFFERENTIATION; CONTROLLED STUDY; GENETIC ASSOCIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; CYTOLOGY; DENDRITIC CELL; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; MOUSE; PHYLOGENY; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL ADHESION MOLECULES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DENDRITIC CELLS; HEK293 CELLS; HUMANS; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84961114155     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150785     Document Type: Article

References (30)

1. Benita, Y., Z. Cao, C. Giallourakis, C. Li, A. Gardet, and R.J. Xavier. 2010. Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood. 115:5376-5384. http://dx.doi.org/10.1182/blood-2010-01-263855
2. Billadeau, D.D., and P.J. Leibson. 2002. ITAMs versus ITIMs: striking a balance during cell regulation. J. Clin. Invest. 109:161-168. http://dx.doi.org/10.1172/JCI0214843
3. Chan, C.J., D.M. Andrews, and M.J. Smyth. 2012. Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer. Curr. Opin. Immunol. 24:246-251. http://dx.doi.org/10.1016/j.coi.2012.01.009
4. Chan, C.J., L. Martinet, S. Gilfillan, F. Souza-Fonseca-Guimaraes, M.T. Chow, L. Town, D.S. Ritchie, M. Colonna, D.M. Andrews, and M.J. Smyth. 2014. The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 15:431-438. http://dx.doi.org/10.1038/ni.2850
5. Chauvin, J.M., O. Pagliano, J. Fourcade, Z. Sun, H. Wang, C. Sander, J.M. Kirkwood, T.H. Chen, M. Maurer, A.J. Korman, and H.M. Zarour. 2015. TIG IT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients. J. Clin. Invest. 125:2046-2058. http://dx.doi.org/10.1172/JCI80445
6. Chen, L., and D.B. Flies. 2013. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13:227-242. http://dx.doi.org/10.1038/nri3405
7. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609-620. http://dx.doi.org/10.1038/nri1148
8. Drake, C.G., E.J. Lipson, and J.R. Brahmer. 2014. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat. Rev. Clin. Oncol. 11:24-37. http://dx.doi.org/10.1038/nrclinonc.2013.208
9. Fuchs, A., M. Cella, E. Giurisato, A.S. Shaw, and M. Colonna. 2004. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J. Immunol. 172:3994-3998. http://dx.doi.org/10.4049/jimmunol.172.7.3994
10. Johnston, R.J., L. Comps-Agrar, J. Hackney, X. Yu, M. Huseni, Y. Yang, S. Park, V. Javinal, H. Chiu, B. Irving, et al. 2014. The immunoreceptor TIG IT regulates antitumor and antiviral CD8+ T cell effector function. Cancer Cell. 26:923-937. http://dx.doi.org/10.1016/j.ccell.2014.10.018
11. Joller, N., J.P. Hafler, B. Brynedal, N. Kassam, S. Spoerl, S.D. Levin, A.H. Sharpe, and V.K. Kuchroo. 2011. Cutting edge: TIG IT has T cell-intrinsic inhibitory functions. J. Immunol. 186:1338-1342. http://dx.doi.org/10.4049/jimmunol.1003081
12. Joller, N., E. Lozano, P.R. Burkett, B. Patel, S. Xiao, C. Zhu, J. Xia, T.G. Tan, E. Sefik, V. Yajnik, et al. 2014. Treg cells expressing the coinhibitory molecule TIG IT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 40:569-581. http://dx.doi.org/10.1016/j.immuni.2014.02.012
13. Leitner, J., W. Kuschei, K. Grabmeier-Pfistershammer, R. Woitek, E. Kriehuber, O. Majdic, G. Zlabinger, W.F. Pickl, and P. Steinberger. 2010. T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells. J. Immunol. Methods. 362:131-141. http://dx.doi.org/10.1016/j.jim.2010.09.020
14. Levin, S.D., D.W. Taft, C.S. Brandt, C. Bucher, E.D. Howard, E.M. Chadwick, J. Johnston, A. Hammond, K. Bontadelli, D. Ardourel, et al. 2011. Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur. J. Immunol. 41:902-915. http://dx.doi.org/10.1002/eji.201041136
15. Liu, J., X. Qian, Z. Chen, X. Xu, F. Gao, S. Zhang, R. Zhang, J. Qi, G.F. Gao, and J. Yan. 2012. Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. J. Immunol. 188:5511-5520. http://dx.doi.org/10.4049/jimmunol.1200324
16. Lozano, E., M. Dominguez-Villar, V. Kuchroo, and D.A. Hafler. 2012. The TIG IT/CD226 axis regulates human T cell function. J. Immunol. 188:3869-3875. http://dx.doi.org/10.4049/jimmunol.1103627
17. Martinet, L., and M.J. Smyth. 2015. Balancing natural killer cell activation through paired receptors. Nat. Rev. Immunol. 15:243-254. http://dx.doi.org/10.1038/nri3799
18. Pauken, K.E., and E.J. Wherry. 2014. TIG IT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkit. Cancer Cell. 26:785-787. http://dx.doi.org/10.1016/j.ccell.2014.11.016
19. Rosenblum, M.D., I.K. Gratz, J.S. Paw, and A.K. Abbas. 2012. Treating human autoimmunity: current practice and future prospects. Sci. Transl. Med. 4:125sr1.
20. Seth, S., M.K. Maier, Q. Qiu, I. Ravens, E. Kremmer, R. Förster, and G. Bernhardt. 2007. The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1. Biochem. Biophys. Res. Commun. 364:959-965. http://dx.doi.org/10.1016/j.bbrc.2007.10.102
21. Shibuya, K., J. Shirakawa, T. Kameyama, S. Honda, S. Tahara-Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, and A. Shibuya. 2003. CD226 (DNAM-1) is involved in lymphocyte functionassociated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198:1829-1839. http://dx.doi.org/10.1084/jem.20030958
22. Stengel, K.F., K. Harden-Bowles, X. Yu, L. Rouge, J. Yin, L. Comps-Agrar, C. Wiesmann, J.F. Bazan, D.L. Eaton, and J.L. Grogan. 2012. Structure of TIG IT immunoreceptor bound to poliovirus receptor reveals a cellcell adhesion and signaling mechanism that requires cis-trans receptor clustering. Proc. Natl. Acad. Sci. USA. 109:5399-5404. http://dx.doi.org/10.1073/pnas.1120606109
23. Tahara-Hanaoka, S., K. Shibuya, Y. Onoda, H. Zhang, S. Yamazaki, A. Miyamoto, S. Honda, L.L. Lanier, and A. Shibuya. 2004. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 16:533-538. http://dx.doi.org/10.1093/intimm/dxh059
24. Tahara-Hanaoka, S., K. Shibuya, H. Kai, A. Miyamoto, Y. Morikawa, N. Ohkochi, S. Honda, and A. Shibuya. 2006. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood. 107:1491-1496. http://dx.doi.org/10.1182/blood-2005-04-1684
25. Takai, Y., J. Miyoshi, W. Ikeda, and H. Ogita. 2008. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat. Rev. Mol. Cell Biol. 9:603-615. http://dx.doi.org/10.1038/nrm2457
26. Yao, S., Y. Zhu, and L. Chen. 2013. Advances in targeting cell surface signalling molecules for immune modulation. Nat. Rev. Drug Discov. 12:130-146. http://dx.doi.org/10.1038/nrd3877
27. Yu, X., K. Harden, L.C. Gonzalez, M. Francesco, E. Chiang, B. Irving, I. Tom, S. Ivelja, C.J. Refino, H. Clark, et al. 2009. The surface protein TIG IT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10:48-57. http://dx.doi.org/10.1038/ni.1674
28. Zhang, T., J. Wang, X. Zhou, R. Liang, Q. Bai, L. Yang, H. Gu, G. Gao, B. Dong, H. Zhu, and X. Chen. 2014. Increased expression of TIG IT on CD4+ T cells ameliorates immune-mediated bone marrow failure of aplastic anemia. J. Cell. Biochem. 115:1918-1927.
29. Zhu, Y., S. Yao, and L. Chen. 2011. Cell surface signaling molecules in the control of immune responses: a tide model. Immunity. 34:466-478. http://dx.doi.org/10.1016/j.immuni.2011.04.008
30. Zhu, Y., S. Yao, B.P. Iliopoulou, X. Han, M.M. Augustine, H. Xu, R.T. Phennicie, S.J. Flies, M. Broadwater, W. Ruff, et al. 2013. B7-H5 costimulates human T cells via CD28H. Nat. Commun. 4:2043. http://dx.doi.org/10.1038/ncomms3043